%0 Journal Article
%T Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of e-cigarette, or vaping, product use-associated lung injury - 10 states, August-October 2019
%J MMWR: Morbidity and mortality weekly report
%D 2019
%A Blount, Benjamin C.
%A Karwowski, Mateusz P.
%A Morel-Espinosa, Maria
%A Rees, Jon
%A Sosnoff, Connie
%A Cowan, Elizabeth
%A Gardner, Michael
%A Wang, Lanqing
%A Valentin-Blasini, Liza
%A Silva, Lalith
%A De Jesús, Víctor R.
%A Kuklenyik, Zsuzsanna
%A Watson, Cliff
%A Seyler, Tiffany
%A Xia, Baoyun
%A Chambers, David
%A Briss, Peter
%A King, Brian A.
%A Delaney, Lisa
%A Jones, Christopher M.
%A Baldwin, Grant T.
%A Barr, John R.
%A Thomas, Jerry
%A Pirkle, James L.
%V 68
%N 45
%P 1040-1041
%X CDC, the Food and Drug Administration (FDA), state and local health departments, and multiple public health and clinical partners are investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). Based on data collected as of October 15, 2019, 86% of 867 EVALI patients reported using tetrahydrocannabinol (THC)-containing products in the 3 months preceding symptom onset (1). Analyses of THC-containing product samples by FDA and state public health laboratories have identified potentially harmful constituents in these products, such as vitamin E acetate, medium chain triglyceride oil (MCT oil), and other lipids (2,3) (personal communication, D.T. Heitkemper, FDA Forensic Chemistry Center, November 2019). Vitamin E acetate, in particular, might be used as an additive in the production of e-cigarette, or vaping, products; it also can be used as a thickening agent in THC products (4). Inhalation of vitamin E acetate might impair lung function (5-7).<p /> <p>Language: en</p>
%G en
%I U.S. Centers for Disease Control and Prevention
%@ 0149-2195
%U http://dx.doi.org/10.15585/mmwr.mm6845e2